As of 11:30 AM on the 4th, Alteogen's stock price is 212,400 KRW, up 9.54% from the previous day, with a trading volume of 1,098,160 shares, which is 217.11% of the 5-day average trading volume. On June 1st, Alteogen was a market topic due to its "strong performance following the announcement of Phase 1 clinical trial results for a breast cancer treatment."
In addition to Alteogen, posts by investors are also surging for Daewoong Pharmaceutical (069620), Ilyang Pharmaceutical (007570), and ABProBio (195990).

※ This article was generated in real-time by an article auto-generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
